Pages that link to "Q24548019"
Jump to navigation
Jump to search
The following pages link to Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma (Q24548019):
Displaying 50 items.
- Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models (Q21245475) (← links)
- Focus on adoptive T cell transfer trials in melanoma (Q21328679) (← links)
- Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells (Q24530100) (← links)
- Adoptive immunotherapy for cancer: building on success (Q24546258) (← links)
- Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy (Q24596055) (← links)
- Thunder and lightning: immunotherapy and oncolytic viruses collide (Q24597894) (← links)
- Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients (Q24598792) (← links)
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen (Q24623215) (← links)
- Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer (Q24630999) (← links)
- T cell receptor gene therapy for cancer (Q24634774) (← links)
- Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens (Q24644442) (← links)
- Adoptive cell transfer: a clinical path to effective cancer immunotherapy (Q24644774) (← links)
- Cancer regression in patients after transfer of genetically engineered lymphocytes (Q24654976) (← links)
- Adoptive T cell therapy for cancer in the clinic (Q24680405) (← links)
- Progress and controversies in developing cancer vaccines (Q24810256) (← links)
- A Perspective of Immunotherapy for Prostate Cancer (Q26741277) (← links)
- Immune Cells in Cancer Therapy and Drug Delivery (Q26747061) (← links)
- Updates in Therapy for Advanced Melanoma (Q26771119) (← links)
- The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer (Q26774678) (← links)
- Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles (Q26777403) (← links)
- Potentiality of immunotherapy against hepatocellular carcinoma (Q26784228) (← links)
- Adoptive T-cell therapy for cancer: The era of engineered T cells (Q26800611) (← links)
- Adoptive T-cell transfer therapy and oncogene-targeted therapy for melanoma: the search for synergy (Q26822793) (← links)
- Current vaccine trials in glioblastoma: a review (Q26828965) (← links)
- Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention (Q26850218) (← links)
- Immunotherapy advances for glioblastoma (Q26866513) (← links)
- Optimal management of metastatic melanoma: current strategies and future directions (Q26997338) (← links)
- Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy? (Q27002575) (← links)
- Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook (Q27004178) (← links)
- Novel immunotherapies for hematologic malignancies (Q27004436) (← links)
- Adoptive T-cell therapy for Leukemia (Q27006934) (← links)
- Toxicities of Immunotherapy for the Practitioner (Q27008140) (← links)
- Clinical application of adoptive T cell therapy in solid tumors (Q27011283) (← links)
- Tumor infiltrating lymphocytes in ovarian cancer (Q27021878) (← links)
- An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma (Q27024830) (← links)
- Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies (Q27027243) (← links)
- Advances in the treatment of metastatic melanoma: adoptive T-cell therapy (Q27027803) (← links)
- Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling (Q27340657) (← links)
- T-cell receptor gene therapy--ready to go viral? (Q28081611) (← links)
- Tumor cell lysates as immunogenic sources for cancer vaccine design (Q28083469) (← links)
- Tumor regression in cancer patients by very low doses of a T cell-engaging antibody (Q28290910) (← links)
- Stimulation of Wnt/ß-catenin pathway in human CD8+ T lymphocytes from blood and lung tumors leads to a shared young/memory phenotype (Q28481655) (← links)
- Enhanced antitumor immunity contributes to the radio-sensitization of ehrlich ascites tumor by the glycolytic inhibitor 2-deoxy-D-glucose in mice (Q28543176) (← links)
- Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1 (Q29616128) (← links)
- Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2 (Q29620608) (← links)
- Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytes (Q30357159) (← links)
- The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptides (Q30423165) (← links)
- In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. (Q30479855) (← links)
- CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor. (Q30573747) (← links)
- TCR-ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transfer (Q30576352) (← links)